Literature DB >> 16451287

Prospective cohort study comparing sequential organ failure assessment and acute physiology, age, chronic health evaluation III scoring systems for hospital mortality prediction in critically ill cirrhotic patients.

Y-C Chen1, Y-C Tian, N-J Liu, Y-P Ho, C Yang, Y-Y Chu, P-C Chen, J-T Fang, C-W Hsu, C-W Yang, M-H Tsai.   

Abstract

The aim of the study was to evaluate the usefulness of sequential organ failure assessment (SOFA) and acute physiology, age, chronic health evaluation III (APACHE III) scoring systems obtained on the first day of intensive care unit (ICU) admission in predicting hospital mortality in critically ill cirrhotic patients. The study enrolled 102 cirrhotic patients consecutively admitted to ICU during a 1-year period. Twenty-five demographic, clinical and laboratory variables were analysed as predicators of survival. Information considered necessary to calculate the Child-Pugh, SOFA and APACHE III scores on the first day of ICU admission was also gathered. Overall hospital mortality was 68.6%. Multiple logistic regression analysis revealed that mean arterial pressure, SOFA and APACHE III scores were significantly related to prognosis. Goodness-of-fit was good for the SOFA and APACHE III models. Both predictive models displayed a similar degree of the best Youden index (0.68) and overall correctness (84%) of prediction. The SOFA and APACHE III models displayed good areas under the receiver-operating characteristic curve (0.917 +/- 0.028 and 0.912 +/- 0.029, respectively). Finally, a strong and significant positive correlation exists between SOFA and APACHE III scores for individual patients (r(2) = 0.628, p < 0.001). This investigation confirms the grave prognosis for cirrhotic patients admitted to ICU. Both SOFA and APACHE III scores are excellent tools to predict the hospital mortality in critically ill cirrhotic patients. The overall predictive accuracy of SOFA and APACHE III is superior to that of Child-Pugh system. The role of these scoring systems in describing the dynamic aspects of clinical courses and allocating ICU resources needs to be clarified.

Entities:  

Mesh:

Year:  2006        PMID: 16451287     DOI: 10.1111/j.1742-1241.2005.00634.x

Source DB:  PubMed          Journal:  Int J Clin Pract        ISSN: 1368-5031            Impact factor:   2.503


  13 in total

1.  Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL) 2014.

Authors:  Shiv Kumar Sarin; Chandan Kumar Kedarisetty; Zaigham Abbas; Deepak Amarapurkar; Chhagan Bihari; Albert C Chan; Yogesh Kumar Chawla; A Kadir Dokmeci; Hitendra Garg; Hasmik Ghazinyan; Saeed Hamid; Dong Joon Kim; Piyawat Komolmit; Suman Lata; Guan Huei Lee; Laurentius A Lesmana; Mamun Mahtab; Rakhi Maiwall; Richard Moreau; Qin Ning; Viniyendra Pamecha; Diana Alcantara Payawal; Archana Rastogi; Salimur Rahman; Mohamed Rela; Anoop Saraya; Didier Samuel; Vivek Saraswat; Samir Shah; Gamal Shiha; Brajesh Chander Sharma; Manoj Kumar Sharma; Kapil Sharma; Amna Subhan Butt; Soek Siam Tan; Chitranshu Vashishtha; Zeeshan Ahmed Wani; Man-Fung Yuen; Osamu Yokosuka
Journal:  Hepatol Int       Date:  2014-09-26       Impact factor: 6.047

2.  Serum lactate level predict mortality in elderly patients with cirrhosis.

Authors:  Adnan Tas; Erdem Akbal; Yavuz Beyazit; Erdem Kocak
Journal:  Wien Klin Wochenschr       Date:  2012-07-19       Impact factor: 1.704

3.  Risk models and scoring systems for predicting the prognosis in critically ill cirrhotic patients with acute kidney injury: a prospective validation study.

Authors:  Heng-Chih Pan; Chang-Chyi Jenq; Ming-Hung Tsai; Pei-Chun Fan; Chih-Hsiang Chang; Ming-Yang Chang; Ya-Chung Tian; Cheng-Chieh Hung; Ji-Tseng Fang; Chih-Wei Yang; Yung-Chang Chen
Journal:  PLoS One       Date:  2012-12-07       Impact factor: 3.240

4.  Prevalence and outcome of cirrhosis patients admitted to UK intensive care: a comparison against dialysis-dependent chronic renal failure patients.

Authors:  Alastair J O'Brien; Cathy A Welch; Mervyn Singer; David A Harrison
Journal:  Intensive Care Med       Date:  2012-03-29       Impact factor: 17.440

5.  Factors that predict short-term intensive care unit mortality in patients with cirrhosis.

Authors:  Ranjeeta Bahirwani; Marwan Ghabril; Kimberly A Forde; Hemant Chatrath; Karen M Wolf; Lindsay Uribe; K Rajender Reddy; Barry Fuchs; Naga Chalasani
Journal:  Clin Gastroenterol Hepatol       Date:  2013-04-16       Impact factor: 11.382

Review 6.  Allocation of patients with liver cirrhosis and organ failure to intensive care: Systematic review and a proposal for clinical practice.

Authors:  Katrine Prier Lindvig; Ane Søgaard Teisner; Jens Kjeldsen; Thomas Strøm; Palle Toft; Valentin Furhmann; Aleksander Krag
Journal:  World J Gastroenterol       Date:  2015-08-07       Impact factor: 5.742

7.  RIFLE classification can predict short-term prognosis in critically ill cirrhotic patients.

Authors:  Chang-Chyi Jenq; Ming-Hung Tsai; Ya-Chung Tian; Chan-Yu Lin; Chun Yang; Nai-Jen Liu; Jau-Min Lien; Yung-Chang Chen; Ji-Tseng Fang; Pan-Chi Chen; Chih-Wei Yang
Journal:  Intensive Care Med       Date:  2007-06-30       Impact factor: 17.440

Review 8.  The effect of diabetes on mortality in critically ill patients: a systematic review and meta-analysis.

Authors:  Sarah E Siegelaar; Maartje Hickmann; Joost B L Hoekstra; Frits Holleman; J Hans DeVries
Journal:  Crit Care       Date:  2011-09-13       Impact factor: 9.097

9.  Prognosis of critically ill cirrhotic versus non-cirrhotic patients: a comprehensive score-matched study.

Authors:  Chung-Ming Fu; Chih-Hsiang Chang; Pei-Chun Fan; Ming-Hung Tsai; Shu-Min Lin; Kuo-Chin Kao; Ya-Chung Tian; Cheng-Chieh Hung; Ji-Tseng Fang; Chih-Wei Yang; Yung-Chang Chen
Journal:  BMC Anesthesiol       Date:  2014-12-17       Impact factor: 2.217

10.  The Royal Free Hospital score: a calibrated prognostic model for patients with cirrhosis admitted to intensive care unit. Comparison with current models and CLIF-SOFA score.

Authors:  Eleni Theocharidou; Giulia Pieri; Ali Omar Mohammad; Michelle Cheung; Evangelos Cholongitas; Banwari Agarwal; Agarwal Banwari; Andrew K Burroughs
Journal:  Am J Gastroenterol       Date:  2014-02-04       Impact factor: 10.864

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.